Want to join the conversation?
$RTN 2Q15 Call: Sales exceeded guidance, increasing by 3% over 2Q14. This was driven by IDS and Missiles and was primarily organic. EPS and cash flow exceeded expectations. Updated financial outlook to reflect solid YTD performance and the acquisition of Websense in late May.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.